 |
|
|
|
|
|
|
|
|
|
|
|
1 to 7 of 7 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Nichols T. on NEWS: Quick-and-Early IVIG Therapy: Hints of Promise, The clinical study of using IVIG in MCI as reported above by Kile is encouraging to those... 9 Apr 2013.
|
|
|
 |
|
|
Nichols T. on NEWS: Dementia Four Times More Likely in Pro Football Players, The science of concussion and chronic traumatic encephalopathy (CTE) is still emerging. Here are... 17 Sep 2012.
|
|
|
|
|
|
Nichols T. on NEWS: Degu Debut—The New Face of Sporadic Alzheimer’s Research?, A most interesting animal model of AD, not only with the Aβ peptide, intracellular and... 7 Sep 2012.
|
|
|
|
|
|
Nichols T. on NEWS: Wave of New BACE Inhibitors Heading to Phase 2, BACE1 inhibition is an important potential theurapeutic arm of the β amyloid clearance... 21 Aug 2012.
|
|
|
|
|
|
Nichols T. on NEWS: Zapping the Brain Can Help, But Where, and With What?, Magnetic induction of current, if done transcranially, is anti-inflammatory. We have studied... 17 Aug 2012.
|
|
|
|
|
|
Nichols T. on NEWS: Stockholm: Therapeutics Roundup—Some New, Some Not So Much, A very important B study, but one lacking a methyl donor with the B6, folate, and B12.... 24 Jul 2012.
|
|
|
|
|
|
Nichols T. on LIVE DISCUSSION: The Pathogen Hypothesis—Challenging the Primacy of Genetics in Late-Onset Alzheimer Disease., As a member of the SfN, we submitted a mini-symposium for the 2006 conference on the possible... 27 Nov 2007.
|
|
|
|
|
|
|
1 to 7 of 7 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
